View article

The Athlete Biological Passport (ABP) relies on the longitudinal monitoring of blood and urine variables impacted by doping use. Since the introduction of the Haematological Module of ABP, it has quickly become a pivotal tool in anti-doping testing. Nevertheless, the ABP has brought new ethical challenges to the anti-doping community. Of particular importance is whether ABP data should be accessible by athletes or not. Such data disclosure could damage the integrity of the anti-doping system as athletes may monitor effectively the results of their doping habits. Moreover, there might be other ramifications resulting from data disclosure. Another issue is how incidental findings within ABP data, such as data indicating a potential underlying pathology, should be reported. In this regard, the inclusion of additional data in the ABP, such as variables involved in hormonal axes or -omics data, could bring new challenges …